Skip to content
10-Q

Quarterly Report

Amneal Pharmaceuticals, Inc. AMRX

0001723128-25-000047

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 314.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 322.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 323.17M sh
Shares Diluted Q2 2025 · Jun 30, 2024 318.96M sh
Shares Diluted Q2 2025 · Jun 30, 2024 308.2M sh
Capex Q2 2025 · Jun 30, 2025 $35.99M
Capex Q2 2025 · Jun 30, 2024 $19.82M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $91.23M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $35.25M
Long Term Debt Q2 2025 · Jun 30, 2025 $2.15B
Long Term Debt Q2 2025 · Dec 31, 2024 $2.16B
Short Term Debt Q2 2025 · Jun 30, 2025 $31.18M
Short Term Debt Q2 2025 · Dec 31, 2024 $224.21M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $71.54M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $110.55M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $43.77M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$112.12M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$109.27M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.11B
Current Liabilities Q2 2025 · Dec 31, 2024 $1.13B
Current Assets Q2 2025 · Jun 30, 2025 $1.58B
Current Assets Q2 2025 · Dec 31, 2024 $1.59B
Total Assets Q2 2025 · Jun 30, 2025 $3.42B
Total Assets Q2 2025 · Dec 31, 2024 $3.5B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.07
Eps Diluted Q2 2025 · Jun 30, 2025 $0.11
Eps Diluted Q2 2025 · Jun 30, 2024 $0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2025 $0.07
Eps Basic Q2 2025 · Jun 30, 2025 $0.11
Eps Basic Q2 2025 · Jun 30, 2024 $0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Sga Expense Q2 2025 · Jun 30, 2025 $124.27M
Sga Expense Q2 2025 · Jun 30, 2025 $242.55M
Sga Expense Q2 2025 · Jun 30, 2024 $116.46M
Sga Expense Q2 2025 · Jun 30, 2024 $229.06M
Rd Expense Q2 2025 · Jun 30, 2025 $47.96M
Rd Expense Q2 2025 · Jun 30, 2025 $88M
Rd Expense Q2 2025 · Jun 30, 2024 $36.05M
Rd Expense Q2 2025 · Jun 30, 2024 $75.35M
Net Income Q2 2025 · Jun 30, 2025 $22.42M
Net Income Q2 2025 · Jun 30, 2025 $34.61M
Net Income Q2 2025 · Jun 30, 2024 $5.99M
Net Income Q2 2025 · Jun 30, 2024 −$85.65M
Operating Income Q2 2025 · Jun 30, 2025 $111.37M
Operating Income Q2 2025 · Jun 30, 2025 $211.72M
Operating Income Q2 2025 · Jun 30, 2024 $95.47M
Operating Income Q2 2025 · Jun 30, 2024 $84.72M
Gross Profit Q2 2025 · Jun 30, 2025 $286.25M
Gross Profit Q2 2025 · Jun 30, 2025 $542.14M
Gross Profit Q2 2025 · Jun 30, 2024 $249.95M
Gross Profit Q2 2025 · Jun 30, 2024 $488.01M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $438.26M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $877.78M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $451.83M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $872.96M
Revenue Q2 2025 · Jun 30, 2025 $724.51M
Revenue Q2 2025 · Jun 30, 2025 $1.42B
Revenue Q2 2025 · Jun 30, 2024 $701.78M
Revenue Q2 2025 · Jun 30, 2024 $1.36B